Clinical Trial Update: Effects of Baclofen on Presynaptic Inhibition in Humans [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating baclofen's effects on presynaptic inhibition in humans has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity
• Spinal Cord Injury

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

Sponsor: University of Alberta | Conditions: Spasticity, Muscle, Spinal Cord Injuries | Phase 2 | Status: WITHDRAWN